Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...

A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...